When Omotayo Olaoye worked as a pharmacist in her native Nigeria, she would track adverse reactions in what she and her colleagues called the “yellow form.” Now, as a newly minted Vanier Scholar, the PhD candidate in pharmacoepidemiology is exploring drug safety for patients with chronic obstructive pulmonary disease. Read more.